MX2010004232A - Compuesto de indolina de pirimidilo. - Google Patents

Compuesto de indolina de pirimidilo.

Info

Publication number
MX2010004232A
MX2010004232A MX2010004232A MX2010004232A MX2010004232A MX 2010004232 A MX2010004232 A MX 2010004232A MX 2010004232 A MX2010004232 A MX 2010004232A MX 2010004232 A MX2010004232 A MX 2010004232A MX 2010004232 A MX2010004232 A MX 2010004232A
Authority
MX
Mexico
Prior art keywords
compound
indoline compound
pyrimidyl
pyrimidyl indoline
disclosed
Prior art date
Application number
MX2010004232A
Other languages
English (en)
Inventor
Toshio Kaneko
Takeshi Shida
Takayuki Baba
Koji Matsumoto
Kazumasa Aoki
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of MX2010004232A publication Critical patent/MX2010004232A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe un compuesto de indolina de pirimidilo que tiene una estructura diferente a la de un compuesto utilizado como un ingrediente activo para un agente hiperglucémico oral convencional, y que tiene una excelente actividad hipergiucémica. Se describe en forma específica un compuesto representado por la fórmula general (I) o una sal farmacéuticamente aceptable del mismo.
MX2010004232A 2007-10-16 2008-10-15 Compuesto de indolina de pirimidilo. MX2010004232A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007268937 2007-10-16
PCT/JP2008/068607 WO2009051119A1 (ja) 2007-10-16 2008-10-15 ピリミジルインドリン化合物

Publications (1)

Publication Number Publication Date
MX2010004232A true MX2010004232A (es) 2010-09-30

Family

ID=40567381

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004232A MX2010004232A (es) 2007-10-16 2008-10-15 Compuesto de indolina de pirimidilo.

Country Status (16)

Country Link
US (1) US8232287B2 (es)
EP (1) EP2210886B1 (es)
JP (1) JP5317354B2 (es)
KR (1) KR101536021B1 (es)
CN (1) CN101896481B (es)
AU (1) AU2008312948C1 (es)
BR (1) BRPI0818338A2 (es)
CA (1) CA2710182C (es)
IL (1) IL205057A0 (es)
MX (1) MX2010004232A (es)
MY (1) MY151295A (es)
NZ (1) NZ585284A (es)
RU (1) RU2464269C2 (es)
TW (1) TWI421074B (es)
WO (1) WO2009051119A1 (es)
ZA (1) ZA201002552B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410089B2 (en) 2009-02-18 2013-04-02 Takeda Pharmaceutical Company Limited Fused heterocyclic ring compound
WO2010128425A1 (en) * 2009-05-08 2010-11-11 Pfizer Inc. Gpr 119 modulators
EP2427448A1 (en) * 2009-05-08 2012-03-14 Pfizer Inc. Gpr 119 modulators
TW201113269A (en) * 2009-06-24 2011-04-16 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto
EP2445878A1 (en) * 2009-06-24 2012-05-02 Boehringer Ingelheim International GmbH New compounds, pharmaceutical composition and methods relating thereto
EP2462123B1 (en) * 2009-08-04 2013-10-02 Merck Sharp & Dohme Corp. 4,5,6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
US20120245344A1 (en) * 2009-08-31 2012-09-27 Nippon Chemiphar Co., Ltd. Gpr119 agonist
WO2011061679A1 (en) * 2009-11-23 2011-05-26 Pfizer Inc. Imidazo-pyrazoles as gpr119 inhibitors
FR2955580A1 (fr) * 2010-01-28 2011-07-29 Sanofi Aventis Derives de carbamate d'alkyl-heterocycles, leur preparation et leur application en therapeutique
CN105837565A (zh) 2010-01-20 2016-08-10 赛诺菲 烷基-杂环氨基甲酸酯衍生物，它们的制备和治疗应用
TW201204733A (en) 2010-06-25 2012-02-01 Kowa Co Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same
WO2012025811A1 (en) * 2010-08-23 2012-03-01 Lupin Limited Indolylpyrimidines as modulators of gpr119
AP2013006812A0 (en) * 2010-10-08 2013-04-30 Cadila Healthcare Ltd Novel GRP 119 agonists
AU2011333472A1 (en) 2010-11-26 2013-06-06 Lupin Limited Bicyclic GPR119 modulators
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013108800A1 (ja) 2012-01-18 2013-07-25 第一三共株式会社 置換フェニルアゾール誘導体
US20160060235A1 (en) * 2013-03-29 2016-03-03 National University Corporation Kumamoto University Therapeutic Agent for Type 2 Diabetes
US20230082516A1 (en) * 2019-01-08 2023-03-16 Kyorin Pharmaceutical Co., Ltd. 15-pgdh inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
OA12097A (en) 1999-11-30 2006-05-04 Pfizer Prod Inc 2,4-Diaminopyrimidine compounds useful as immunosuppressants.
US7101869B2 (en) * 1999-11-30 2006-09-05 Pfizer Inc. 2,4-diaminopyrimidine compounds useful as immunosuppressants
AU2003237746B8 (en) 2002-06-19 2010-01-28 Proximagen Limited Novel process
US7078419B2 (en) * 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
UA86943C2 (ru) * 2003-07-11 2009-06-10 Арена Фармасьютикалз, Инк. Тризамещенные производные арилов и гетероарилов как модуляторы метаболизма и профилактика и лечение связанных с ними нарушений
FR2866884B1 (fr) 2004-02-26 2007-08-31 Sanofi Synthelabo Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
UA92150C2 (ru) 2004-06-04 2010-10-11 Арена Фармасьютикалз, Инк. Замещенные производные арила и гетероарила как модуляторы метаболизма и для профилактики и лечения связанных с ним расстройств
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
AU2006264649A1 (en) * 2005-06-30 2007-01-11 Prosidion Limited GPCR agonists
US8222261B2 (en) * 2006-07-13 2012-07-17 GlaxoSmithKline, LLC Chemical compounds

Also Published As

Publication number Publication date
TW200922588A (en) 2009-06-01
US8232287B2 (en) 2012-07-31
RU2464269C2 (ru) 2012-10-20
AU2008312948B2 (en) 2012-03-01
CA2710182C (en) 2012-08-14
ZA201002552B (en) 2011-10-26
KR101536021B1 (ko) 2015-07-10
TWI421074B (zh) 2014-01-01
BRPI0818338A2 (pt) 2015-04-22
JP5317354B2 (ja) 2013-10-16
AU2008312948C1 (en) 2012-08-09
IL205057A0 (en) 2010-11-30
MY151295A (en) 2014-04-30
NZ585284A (en) 2011-03-31
JPWO2009051119A1 (ja) 2011-03-03
CA2710182A1 (en) 2009-04-23
AU2008312948A1 (en) 2009-04-23
EP2210886B1 (en) 2015-09-23
WO2009051119A1 (ja) 2009-04-23
EP2210886A4 (en) 2011-08-17
CN101896481A (zh) 2010-11-24
RU2010119487A (ru) 2011-11-27
KR20100071068A (ko) 2010-06-28
EP2210886A1 (en) 2010-07-28
CN101896481B (zh) 2014-04-30
US20100292259A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
MX2010004232A (es) Compuesto de indolina de pirimidilo.
TW200728307A (en) Novel spirochromanone derivatives
WO2007135527A3 (en) Benzimidazolyl compounds
WO2010026436A3 (en) 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders
MX2007004699A (es) Derivados de indol y bencimidazol.
TW200612958A (en) Substituted imidazole derivatives
WO2007117465A3 (en) Indazole compounds
UA105229C2 (uk) Фармацевтичний склад
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
WO2010136474A3 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
WO2007084728A3 (en) 2-imino-benzimidazoles
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
MY147188A (en) Substituted imidazole compounds as ksp inhibitors
MX2012002528A (es) Agente terapeutico para trastornos del estado de animo.
TN2013000257A1 (en) Immunosuppressant formulations
AU2010321366A8 (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2009096667A3 (ko) 신규한 퀴나졸린-2,4-디온 유도체 및 이를 함유하는 뇌신경질환 예방 및 치료용 의약 조성물
TN2012000093A1 (en) Therapeutic agent for anxiety disorders
MX2013005965A (es) Nuevos compuestos de triazol iii.
MY160963A (en) Sustained-release therapeutic agent for hypertension and renal dysfunction
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof

Legal Events

Date Code Title Description
FG Grant or registration